In State Of The Union, Obama Highlights Need For Patent Reform, Trade 29/01/2014 by Intellectual Property Watch 1 Comment In the annual State of the Union speech of the United States president to Congress last night, President Obama described an innovation race, and highlighted the importance of trade agreements and passage of patent reform legislation.
At WIPO, Nations See Different Needs From Patent System 27/01/2014 by William New, Intellectual Property Watch 1 Comment An important international platform that has seen stark differences in the past, the World Intellectual Property Organization Standing Committee on the Law of Patents (SCP) began a weeklong meeting today on improving the patent system with parties promoting their own interests and asking straightforward questions of others.
WHO Sets Path For Model R&D Projects For Developing Countries 25/01/2014 by William New, Intellectual Property Watch 2 Comments Members of the World Health Organization Executive Board this week moved forward on the long path to new ways to spur research and development for diseases that mainly afflict poor populations. A process has been set for considering – and potentially choosing among – eight projects before the annual World Health Assembly in May.
WHO Board Adopts Resolution On Medicines Access After TRIPS Flexibilities Debate 25/01/2014 by William New, Intellectual Property Watch Leave a Comment The sometimes tense issue of intellectual property rights flexibilities built into international trade rules on IP briefly threatened to trip up a proposal on access to medicines today at the World Health Organization. But members managed to steer the debate to consensus on a text that will now head to the full membership for approval in May.
WHO Board Addresses Substandard Medicines, Flu Pandemics, Regulatory Systems 24/01/2014 by Catherine Saez, Intellectual Property Watch Leave a Comment The World Health Organization Executive Board got through a high number of items yesterday, including several with ramifications for intellectual property and innovation.
WHO Chief: No Government Should Be Intimidated For Doing “Right Thing” In Public Health 24/01/2014 by Catherine Saez, Intellectual Property Watch 4 Comments Discussions on access to essential medicines yesterday at the World Health Organization were in some ways overshadowed by the recent leak of a global pharmaceutical campaign aimed at derailing efforts by the South African government to revise its intellectual property policy. WHO Director General Margaret Chan strongly supported South Africa, as did several developing countries, while developed countries remained silent on the subject.
WHO Board Tackles Reform, Engagement With Non-State Actors 24/01/2014 by Catherine Saez, Intellectual Property Watch 5 Comments The World Health Organization Executive Board spent long hours this week discussing the progress of the reform of the organisation. Among items covered were the reform implementation plan, the engagement of WHO with non-state actors, and ways to improve decision-making by the organisation’s governing bodies.
Year Ahead: Copyright Issues Top EU IP Policy In 2014 23/01/2014 by Dugie Standeford for Intellectual Property Watch Leave a Comment Copyright tops the European Union intellectual property agenda this year, with completion of a collective rights management directive, and European Commission statements on IP rights enforcement and possible revisions to EU copyright rules, due this spring. “Steady progress” on rollout of a unified EU patent and patent court system is expected, and trademark and other issues also figure prominently. But with European Parliament elections in May, and a new Commission in November, the timetables for these and other IP-related issues could shift, the EC and others said.
Global Health 2035 Report: Flawed Projections 23/01/2014 by Intellectual Property Watch 3 Comments Daniele Dionisio writes: Hopes that a comprehensive global health goal could be reached by 2035 are hardly credible with the load of unresolved issues still on the table. This article turns the spotlight on much-debated relevant questions that were left out or under-scrutinised in a recently published Lancet report.
New Health Collaboration Touts Ethics, Aims To Put Patients First 22/01/2014 by Catherine Saez, Intellectual Property Watch Leave a Comment Several health care organisations this week signed a “consensus framework” for ethical collaboration between patients’ organisations, healthcare professionals, and the pharmaceutical industry.